Juvaris BioTherapeutics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Juvaris BioTherapeutics General Information

Description

Developer of adjuvanted vaccines and immunotherapeutics designed to treat infectious disease and cancer. The company's adjuvanted vaccines and immunotherapeutics enhance the effect of vaccines by increasing the quantity and quality of the immune response and reducing the amount of antigen required in the vaccine, enabling patients to access improved treatment and up-regulate the immune system.

Contact Information

Website
www.juvaris.com
Formerly Known As
Juvaris Bis Therapeutics Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • P.O. Box 208
  • Pleasanton, CA 94566
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Colby Pharmaceutical
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • P.O. Box 208
  • Pleasanton, CA 94566
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Juvaris BioTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition Completed Generating Revenue
4. Later Stage VC 25-Oct-2010 Completed Profitable
3. Later Stage VC (Series B) 23-Sep-2009 Completed Generating Revenue
2. Later Stage VC (Series A) 05-Dec-2008 $18.5M $18.5M Completed Generating Revenue
1. Grant 01-Jan-2008 $3.81M Completed Generating Revenue
To view Juvaris BioTherapeutics’s complete valuation and funding history, request access »

Juvaris BioTherapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Juvaris BioTherapeutics’s complete cap table history, request access »

Juvaris BioTherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of adjuvanted vaccines and immunotherapeutics designed to treat infectious disease and cancer. The company's a
Drug Discovery
Pleasanton, CA

Plymouth Meeting, PA
 

Wilmington, DE
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Juvaris BioTherapeutics Competitors (20)

One of Juvaris BioTherapeutics’s 20 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Ayala Pharmaceuticals Corporation Wilmington, DE
Verastem Formerly VC-backed Needham, MA
Vertex Pharmaceuticals Formerly VC-backed Boston, MA
CaroGen Venture Capital-Backed Farmington, CT
You’re viewing 5 of 20 competitors. Get the full list »

Juvaris BioTherapeutics Patents

  • 54

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • Pending

  • Expiring in next 12 mo

Juvaris BioTherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130171234-A1 Subunit vaccines for herpes viruses and methods of use Active 26-Feb-2010
US-9089537-B2 Subunit vaccines for herpes viruses and methods of use Active 26-Feb-2010
WO-2011106607-A2 Subunit vaccines for herpes viruses and methods of use Inactive 26-Feb-2010
WO-2011106607-A3 Subunit vaccines for herpes viruses and methods of use Inactive 26-Feb-2010
CA-2758965-A1 Method for the preparation of amphiphilic imidazolinium compounds Active 29-Apr-2009 C07D233/60
To view Juvaris BioTherapeutics’s complete patent history, request access »

Juvaris BioTherapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
CSU Starta Corporation Minority
Kleiner Perkins Venture Capital Minority
SV Health Investors PE/Buyout Minority
TriplePoint Capital Venture Capital Minority
U.S. Department of Health and Human Services Government
To view Juvaris BioTherapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Juvaris BioTherapeutics FAQs

  • When was Juvaris BioTherapeutics founded?

    Juvaris BioTherapeutics was founded in 2001.

  • Where is Juvaris BioTherapeutics headquartered?

    Juvaris BioTherapeutics is headquartered in Pleasanton, CA.

  • What industry is Juvaris BioTherapeutics in?

    Juvaris BioTherapeutics’s primary industry is Drug Discovery.

  • Is Juvaris BioTherapeutics a private or public company?

    Juvaris BioTherapeutics is a Private company.

  • What is Juvaris BioTherapeutics’s current revenue?

    The current revenue for Juvaris BioTherapeutics is .

  • How much funding has Juvaris BioTherapeutics raised over time?

    Juvaris BioTherapeutics has raised $44.3M.

  • Who are Juvaris BioTherapeutics’s investors?

    CSU Starta, Kleiner Perkins, SV Health Investors, TriplePoint Capital, and U.S. Department of Health and Human Services have invested in Juvaris BioTherapeutics.

  • Who are Juvaris BioTherapeutics’s competitors?

    Inovio Pharmaceuticals, Ayala Pharmaceuticals, Verastem, Vertex Pharmaceuticals, and CaroGen are some of the 20 competitors of Juvaris BioTherapeutics.

  • Who acquired Juvaris BioTherapeutics?

    Juvaris BioTherapeutics was acquired by Colby Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process